» Articles » PMID: 22744873

Craniopharyngioma: History

Overview
Journal Pituitary
Specialty Endocrinology
Date 2012 Jun 30
PMID 22744873
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

One of the most challenging parasellar tumors, the craniopharyngioma was first described by Friedrich Albert von Zenker in 1857. Following improved understanding of pituitary gland physiology and development, Jakob Erdheim became the first to accurately describe the histopathological characteristics of a craniopharyngioma. Babinski's described the clinical presentation of these patients, with "sexual infantilism and dystrophic adiposity." The first successful surgical resection of a craniopharyngioma was performed by A. E. Halstead of Chicago of July 21st, 1909. Harvey Cushing embraced the transsphenoidal approach for the majority of his pituitary operations, but favored the transcranial approach for craniopharyngiomas. The introduction of antibiotics, corticosteroids, and microscopy significantly improved surgical outcomes. As technology improved, trans-cranial and transsphenoidal approaches were implemented depending on tumor characteristics. Adjuvant therapy, such as stereotactic radiosurgery, radioisotope brachytherapy, and intracapsular chemotherapy have improved overall tumor control rates and decreased the incidence of complications. Building on over 100 years of surgery for "the most formidable of intracranial tumors," results continue to improve. Regardless, challenges continue to remain requiring surgical insight and innovation.

Citing Articles

A Reliable Closure Technique for Retromastoid Craniotomy to Avoid Cerebrospinal Fluid Leaks and Meningitis.

Barkhoudarian G, Garling R, Mallari R, Sivakumar W, Kelly D Neurosurg Pract. 2025; 5(3):e00086.

PMID: 39959895 PMC: 11783628. DOI: 10.1227/neuprac.0000000000000086.


Comprehensive Analysis of Craniopharyngioma: Epidemiology, Clinical Characteristics, Management Strategies, and Role of Radiotherapy.

Mushtaq A, Fayaz M, Bhat A, Hussein A, Ferini G, Umana G Cancer Diagn Progn. 2024; 4(4):521-528.

PMID: 38962549 PMC: 11215458. DOI: 10.21873/cdp.10358.


Evolution of Surgical Outcomes in Endoscopic Endonasal Resection of Craniopharyngiomas.

Yu S, Taghvaei M, Reyes M, Collopy S, Piper K, Karsy M J Neurol Surg B Skull Base. 2023; 84(4):375-383.

PMID: 37405242 PMC: 10317569. DOI: 10.1055/s-0042-1751291.


Integrin 6 Indicates a Poor Prognosis of Craniopharyngioma through Bioinformatic Analysis and Experimental Validation.

Jia Y, Wu W, Xiao Y, Cai K, Gui S, Li Q J Oncol. 2022; 2022:6891655.

PMID: 36268277 PMC: 9578790. DOI: 10.1155/2022/6891655.


Current Advances in the Management of Adult Craniopharyngiomas.

Lara-Velazquez M, Mehkri Y, Panther E, Hernandez J, Rao D, Fiester P Curr Oncol. 2022; 29(3):1645-1671.

PMID: 35323338 PMC: 8946973. DOI: 10.3390/curroncol29030138.


References
1.
Konovalov A, Gorelyshev S . Surgical treatment of anterior third ventricle tumours. Acta Neurochir (Wien). 1992; 118(1-2):33-9. DOI: 10.1007/BF01400724. View

2.
Shi X, Wu B, Fan T, Zhou Z, Zhang Y . Craniopharyngioma: surgical experience of 309 cases in China. Clin Neurol Neurosurg. 2007; 110(2):151-9. DOI: 10.1016/j.clineuro.2007.10.013. View

3.
Kassam A, Gardner P, Snyderman C, Carrau R, Mintz A, Prevedello D . Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum. J Neurosurg. 2008; 108(4):715-28. DOI: 10.3171/JNS/2008/108/4/0715. View

4.
GORDY P, Peet M, Kahn E . The surgery of the craniopharyngiomas. J Neurosurg. 1949; 6(6):503-17. DOI: 10.3171/jns.1949.6.6.0503. View

5.
LOVE J, MARSHALL T . Craniopharyngiomas. Surg Gynecol Obstet. 1950; 90(5):591-601. View